Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension

Published:2017-01 Issue:1 Volume:7 Page:186-199
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Egnatchik Robert A.¹²,Brittain Evan L.³,Shah Amy T.⁴,Fares Wassim H.⁵,Ford H. James⁶,Monahan Ken³,Kang Christie J.⁷,Kocurek Emily G.⁷,Zhu Shijun⁷,Luong Thong⁷,Nguyen Thuy T.⁸,Hysinger Erik⁹,Austin Eric D.¹⁰,Skala Melissa C.⁴¹¹,Young Jamey D.²¹²,Roberts L. Jackson⁸,Hemnes Anna R.⁷,West James⁴⁷,Fessel Joshua P.⁷⁸¹¹

Affiliation:

1. Children’s Medical Center Research InstituteUniversity of Texas SouthwesternDallasTXUSA

2. Department of Chemical and Biomolecular EngineeringVanderbilt UniversityNashvilleTNUSA

3. Division of Cardiovascular Medicine and the Vanderbilt Translational and Clinical Cardiovascular CenterDepartment of MedicineVanderbilt University Medical CenterNashvilleTNUSA

4. Department of Biomedical EngineeringVanderbilt UniversityNashvilleTNUSA

5. Section of Pulmonary, Critical Care & Sleep MedicineDepartment of MedicineYale UniversityNew HavenCTUSA

6. Division of Pulmonary Diseases and Critical Care MedicineDepartment of MedicineUniversity of North Carolina Chapel HillChapel HillNCUSA

7. Division of AllergyPulmonary and Critical Care MedicineDepartment of MedicineVanderbilt University Medical CenterNashvilleTNUSA

8. Department of PharmacologyVanderbilt UniversityNashvilleTNUSA

9. Division of Pulmonary MedicineChildren’s Hospital of PhiladelphiaPhiladelphiaPAUSA

10. Division of Pulmonary MedicineDepartment of PediatricsVanderbilt University Medical CenterNashvilleTNUSA

11. Department of Cancer BiologyVanderbilt UniversityNashvilleTNUSA

12. Department of Molecular Physiology and BiophysicsVanderbilt UniversityNashvilleTNUSA

Funder

National Institutes of Health

American Heart Association

Actelion Pharmaceuticals

National Center for Advancing Translational Sciences

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1086/690236

Reference59 articles.

1. The metabolic basis of pulmonary arterial hypertension;Sutendra G;Cell Metab,2014

2. Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension;Ryan JJ;Circulation,2015

3. Assessing cardiac metabolism: a scientific statement from the American Heart Association;Taegtmeyer H;Circ Res,2016

4. Endothelial cell metabolism in normal and diseased vasculature;Eelen G;Circ Res,2015

5. Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension;Gomez‐Arroyo J;Circ Heart Fail,2013

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multimodal approach identifies lactate as a central feature of right ventricular failure that is detectable in human plasma;Frontiers in Medicine;2024-09-12

2. Viewing Pulmonary Arterial Hypertension Pathogenesis and Opportunities for Disease-Modifying Therapy Through the Lens of Biomass;JACC: Basic to Translational Science;2024-07

3. B4 suppresses lymphoma progression by inhibiting fibroblast growth factor binding protein 1 through intrinsic apoptosis;Frontiers in Pharmacology;2024-06-28

4. Hypoxia-induced pulmonary hypertension in adults and newborns: implications for drug development;Drug Discovery Today;2024-06

5. Unveiling the metabolic landscape of pulmonary hypertension: insights from metabolomics;Respiratory Research;2024-05-28